Skip to main content
Clinical Trials/NCT04663269
NCT04663269
Terminated
Phase 4

Randomized, Prospective Trial of Regional Erector Spinae Analgesic Block Versus Standard of Care in Patients Undergoing Percutaneous Nephrolithotomy

Indiana University1 site in 1 country5 target enrollmentFebruary 24, 2020

Overview

Phase
Phase 4
Intervention
Control Test
Conditions
Kidney Stone
Sponsor
Indiana University
Enrollment
5
Locations
1
Primary Endpoint
Overnight Admission Rate
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to determine if adding a spinal block (medicine that will numb parts of the body to block pain) along with standard pain control at the incision site will decrease the need for narcotics for pain management and decrease the percentage of patients requiring hospital admission for pain control during postoperative , in-hospital, care after a percutaneous nephrolithotomy (PCNL) (surgery to remove kidney stones), commonly called PERC.

Registry
clinicaltrials.gov
Start Date
February 24, 2020
End Date
September 24, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tim Large

Assistant Professor of Urology

Indiana University

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years Undergoing unilateral or bilateral PCNL for treatment of kidney stones Estimated glomerular filtration rate \> 30 mL/min. PCNL is planned as an outpatient procedure with no overnight hospital stay

Exclusion Criteria

  • Inability to provide informed consent Pregnancy Patients having any additional simultaneous procedures other than a contralateral PCNL,(including contralateral treatment of kidney stones with a non-PCNL operation such as ureteroscopy) Patients with a documented neurologic injury that reduces pain sensation to the back Patients with an existing pain disorder Patients with an existing narcotics agreement due to current or prior narcotic abuse Patients with a documented allergy to a narcotic or NSAID analgesic BMI \> 35 Patients who require more than 1 site of percutaneous access into the kidney to adequately complete the PCNL (this is a judgment made preoperatively at the initial clinic patient encounter)

Arms & Interventions

Control

Standard Care Protocol - peritubal block standard local analgesic administration in the form of a peritubal block

Intervention: Control Test

ANES Block

Patients randomized to the erector spinae block (Group 2) will have the block placed in the preoperative area by the anesthesia team. 0-4 mg midazolam and/or 0-100 mcg of fentanyl may be provided prior to and in order to place the block itself. The local anesthetic will diffuse to involve the dorsal and ventral rami of the spinal nerves, achieving a sensory block of the affected area. The erector spinae block analgesic will be administered by the anesthesia team. The analgesic provided in the erector spinae block is 20mL of 0.5% Bupivicaine with 4mg of PF Dexamethasone.

Intervention: 4mg PF Dexamethasone

Outcomes

Primary Outcomes

Overnight Admission Rate

Time Frame: 24 hours

Percentage of patients in Groups 1 and 2 who require overnight admission to the hospital for pain control postoperatively (i.e. patients unable to be discharged to home from the postoperative anesthesia care unit PACU).

Secondary Outcomes

  • Pain Score(24 hours)
  • Narcotic for Analgesia post-operatively(14 days post-op)
  • Number of complications peri and post-operatively(24 hours)
  • Rate of Adjunct Analgesics Post-operatively(14 days)
  • Proportion of patients with Emergency Department return or re-admission(14 days)
  • Number of Narcotic administrations post-operatively(14 days)
  • Number of Morphine Equivalents post-operatively(14 days)

Study Sites (1)

Loading locations...

Similar Trials